C12N 2710/10345
Special targeting system for viral vectors
C12N2710/10345 (Special targeting system for viral vectors) appears on 147 US grants and 237 published applications in this corpus.
Search patents in C12N- Granted patents
- 147
- Published applications
- 237
- Assignees
- 107
- Inventors
- 372
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 5 |
| 2002 | 7 | 19 |
| 2003 | 14 | 26 |
| 2004 | 6 | 27 |
| 2005 | 11 | 11 |
| 2006 | 7 | 17 |
| 2007 | 6 | 10 |
| 2008 | 6 | 13 |
| 2009 | 3 | 11 |
| 2010 | 3 | 8 |
| 2011 | 4 | 10 |
| 2012 | 5 | 9 |
| 2013 | 3 | 7 |
| 2014 | 8 | 7 |
| 2015 | 7 | 8 |
| 2016 | 4 | 4 |
| 2017 | 4 | 6 |
| 2018 | 3 | 6 |
| 2019 | 5 | 4 |
| 2020 | 0 | 4 |
| 2021 | 2 | 5 |
| 2022 | 3 | 5 |
| 2023 | 6 | 3 |
| 2024 | 2 | 5 |
| 2025 | 4 | 6 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Rescue of recombinant adenoviruses by CRISPR/Cas-mediated in vivo terminal resolution25 Aug 2026US 12,716,064 B2Albert-Ludwigs-Universität Freiburg
- Adenosomes7 Oct 2025US 12,435,110 B2Erasmus University Medical Center Rotterdam
- Adenovirus comprising a modified adenovirus hexon protein7 Oct 2025US 12,435,112 B2UniversitäT Ulm
- Modified adenoviruses3 Jun 2025US 12,318,418 B2University College Cardiff Consultants Limited
- Oncolytic virus expressing interferon and application therefor3 Jun 2025US 12,319,931 B2Shanghai Yuansong Biotechnology Co. Ltd.
- Paracrine Adenoviral Delivery of Biomolecules16 Apr 2026US 2026/0103541 A1UniversitäT ZüRich
- Immune-cloaking antitumor adenovirus18 Dec 2025US 2025/0382634 A1Curigin Co., Ltd.
- Adenoviral vector-based vaccine for emerging viruses13 Nov 2025US 2025/0345414 A1Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet)
- Rescue of recombinant adenoviruses by crispr/cas-mediated in vivo terminal resolution28 Aug 2025US 2025/0270545 A1Albert-Ludwigs-Universität Freiburg
- Adenoviral Mediated Targeting of Activated Immune Cells3 Jul 2025US 2025/0215452 A1UniversitäT ZüRich
Most cited
By later US patents
- Targeting adenovirus with use of constrained peptide motifs158US 5,846,782 AGenVec, Inc. · 1998
- Adenovirus with modified binding moiety specific for the target cells150US 5,885,808 AImperial Cancer Research Technology, Ltd. · 1999
- Penton base protein and methods of using same136US 5,559,099 AGenVec, Inc. · 1996
- Methods and compositions for gene inactivation111US 7,951,925 B2Sangamo BioSciences, Inc. · 2011
- Vectors and methods for gene transfer to cells80US 5,965,541 AGenVec, Inc. · 1999